Access to Care for Multiple Sclerosis in Times of Economic Crisis in Greece – the HOPE II Study
Publish Year: 1395
نوع سند: مقاله ژورنالی
زبان: English
View: 58
This Paper With 7 Page And PDF Format Ready To Download
- Certificate
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_HPM-5-2_002
تاریخ نمایه سازی: 16 مرداد 1403
Abstract:
Background While there is currently no cure for multiple sclerosis (MS), treatment with biologic diseasemodifying drugs (bDMDs) can reduce the impact of the condition on the lives of patients. In Greece, the regulatory change in the distribution system of bDMDs, limited their administration through the designated pharmacies of the National Organization for Healthcare Services Provision (EOPYY) or the National Health System (ESY) hospitals, thus potentially impacting access to MS treatment. In this context, the aim of this paper was to assess the barriers to bDMDs, by recording MS patients’ experiences. Methods A survey research was conducted between January and February ۲۰۱۴ in Athens and ۵ other major Greek cities with the methods of personal and telephone interview. A structured questionnaire was used to elicit socio-economic and medical information, information related to obstacles in accessing bDMDs and medical treatment, from MS patients that visited EOPYY pharmacies during the study period. Results During the last year ۶۹% of ۱۷۹ participants reported that the distribution system of bDMDs has improved. Thirteen percent of participants encountered problems in accessing their medication, and ۱۶.۹% of participants in accessing their physician, with the obstacles being more pronounced for non-Athens residents. Frequent obstacles to bDMDs were the distance from EOPYY pharmacies and difficulties in obtaining a diagnosis from an EOPYY/ESY physician, while obstacles to medical care were delays in appointment booking and travel difficulties. Conclusion Even though the major weaknesses of the distribution system of bDMDs have improved, further amelioration of the system could be achieved through the home delivery of medicines to patients living in remote areas, and through the development of a national MS registry.
Keywords:
Authors
Kyriakos Souliotis
Faculty of Social and Political Sciences, University of Peloponnese, Corinth, Greece
Elena Alexopoulou
Faculty of Social Sciences, University of Peloponnese, Corinth, Greece
Manto Papageorgiou
Faculty of Social Sciences, University of Peloponnese, Corinth, Greece
Anastasia Politi
Department of Statistics, Athens University of Economics and Business, Athens, Greece
Panagiota Litsa
Centre for Health Services Research, Medical School, University of Athens, Athens, Greece
Xenophon Contiades
Faculty of Social Sciences, University of Peloponnese, Corinth, Greece
مراجع و منابع این Paper:
لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :